Abstract
Use of exogenous estrogens has been associated with endometrial cancer in a number of case-control studies. This observed association could be biased as a result of frequent misclassification of estrogen-induced hyperplasia as endometrial cancer. To evaluate this possibility, pathology slides from 233 patients with a hospital diagnosis of endometrial cancer were reviewed independently by two pathologists. The hospital diagnosis was confirmed by both pathologists in 86% of the cases, indicating that the misclassification of hyperplasia as carcinoma is uncommon.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 12-15 |
| Number of pages | 4 |
| Journal | Obstetrics and gynecology |
| Volume | 64 |
| Issue number | 1 |
| State | Published - Jul 1984 |
ASJC Scopus subject areas
- Obstetrics and Gynecology